Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QFDKM
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
RAD-502
|
|||||
| Synonyms |
RAD 502; RAD502; Lutetium-177 labeled humanized monoclonal antibody targeting leucine rich repeat containing 15 (LRRC15)
Click to Show/Hide
|
|||||
| Organization |
Radiopharm Theranostics Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Osteosarcoma [ICD11:2B51]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Leucine-rich repeat-containing protein 15 (LRRC15)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Special Approval(s) |
Orphan drug(FDA)
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.